Foley Mark J
Revance Therapeutics, Inc. - Common Stock · CEO
Foley Mark J is listed in public filings as director, officer: CEO. This Foley Mark J insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Revance Therapeutics, Inc. - Common Stock (RVNC), and Glaukos Corporation (GKOS). Investors use Foley Mark J's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $2.5M20.7k shares | SellFeb 26, 2025 | $120.72 | -- |